 | • レポートコード：MRC2312MG02788 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥455,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥682,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の標的放射性医薬品市場規模と予測を収録しています。・世界の標的放射性医薬品市場：売上、2018年-2023年、2024年-2029年 ・世界の標的放射性医薬品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の標的放射性医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「標的治療用放射性医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 標的放射性医薬品のグローバル主要企業は、Novartis、 Bayer、 Lantheus、 Institute for Radioelements (IRE)、 Radiomedix、 Curium Pharma、 Clarity Pharmaceuticals、 ROTOP、 Ratio Therapeutics、 Fusion Pharmaceuticals、 Perspective Therapeutics、 RayzeBio、 Alpha-9 Theranostics、 Radiopharm Theranostics、 Telix Pharmaceuticals、 Ariceum Therapeutics、 Aktis Oncology、 Navidea Biopharmaceuticals、 Nucleus RadioPharma、 SmartNuclide Biopharma、 TetraKit Technologiesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、標的放射性医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の標的放射性医薬品市場：タイプ別、2018年-2023年、2024年-2029年 世界の標的放射性医薬品市場：タイプ別市場シェア、2022年 ・標的治療用放射性医薬品、標的診断用放射性医薬品 世界の標的放射性医薬品市場：用途別、2018年-2023年、2024年-2029年 世界の標的放射性医薬品市場：用途別市場シェア、2022年 ・標的治療、標的診断 世界の標的放射性医薬品市場：地域・国別、2018年-2023年、2024年-2029年 世界の標的放射性医薬品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における標的放射性医薬品のグローバル売上、2018年-2023年 ・主要企業における標的放射性医薬品のグローバル売上シェア、2022年 ・主要企業における標的放射性医薬品のグローバル販売量、2018年-2023年 ・主要企業における標的放射性医薬品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Novartis、 Bayer、 Lantheus、 Institute for Radioelements (IRE)、 Radiomedix、 Curium Pharma、 Clarity Pharmaceuticals、 ROTOP、 Ratio Therapeutics、 Fusion Pharmaceuticals、 Perspective Therapeutics、 RayzeBio、 Alpha-9 Theranostics、 Radiopharm Theranostics、 Telix Pharmaceuticals、 Ariceum Therapeutics、 Aktis Oncology、 Navidea Biopharmaceuticals、 Nucleus RadioPharma、 SmartNuclide Biopharma、 TetraKit Technologies ************************************************************* ・調査・分析レポートの概要 標的放射性医薬品市場の定義 市場セグメント 世界の標的放射性医薬品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の標的放射性医薬品市場規模 世界の標的放射性医薬品市場規模：2022年 VS 2029年 世界の標的放射性医薬品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの標的放射性医薬品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の標的放射性医薬品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：標的治療用放射性医薬品、標的診断用放射性医薬品 標的放射性医薬品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：標的治療、標的診断 標的放射性医薬品の用途別グローバル売上・予測 ・地域別市場分析 地域別標的放射性医薬品市場規模 2022年と2029年 地域別標的放射性医薬品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Novartis、 Bayer、 Lantheus、 Institute for Radioelements (IRE)、 Radiomedix、 Curium Pharma、 Clarity Pharmaceuticals、 ROTOP、 Ratio Therapeutics、 Fusion Pharmaceuticals、 Perspective Therapeutics、 RayzeBio、 Alpha-9 Theranostics、 Radiopharm Theranostics、 Telix Pharmaceuticals、 Ariceum Therapeutics、 Aktis Oncology、 Navidea Biopharmaceuticals、 Nucleus RadioPharma、 SmartNuclide Biopharma、 TetraKit Technologies ... |
This research report provides a comprehensive analysis of the Targeted Radiopharmaceuticals market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Targeted Radiopharmaceuticals market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Targeted Radiopharmaceuticals, challenges faced by the industry, and potential opportunities for market players.
The global Targeted Radiopharmaceuticals market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Targeted Radiopharmaceuticals market presents opportunities for various stakeholders, including Targeted Therapy, Targeted Diagnosis. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Targeted Radiopharmaceuticals market. Additionally, the growing consumer demand present avenues for market expansion.
The global Targeted Radiopharmaceuticals market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The radiopharmaceuticals market had been experiencing steady growth and significant interest due to the increasing use of nuclear medicine procedures for diagnostic and therapeutic purposes. Radiopharmaceuticals are essential tools in nuclear medicine, and they play a crucial role in diagnosing various diseases, such as cancer, cardiovascular conditions, and neurological disorders.
The radiopharmaceuticals market had been growing steadily over the years. Factors contributing to this growth include advancements in radiopharmaceutical development, rising prevalence of cancer and cardiovascular diseases, and an aging population that drives the demand for diagnostic procedures.
Key Features:
The research report on the Targeted Radiopharmaceuticals market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Targeted Radiopharmaceuticals market.
Market Overview: The report provides a comprehensive overview of the Targeted Radiopharmaceuticals market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Targeted Therapeutic Radiopharmaceuticals, Targeted Diagnostic Radiopharmaceuticals), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Targeted Radiopharmaceuticals market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Targeted Radiopharmaceuticals market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Targeted Radiopharmaceuticals market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Targeted Radiopharmaceuticals market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Targeted Radiopharmaceuticals market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Targeted Radiopharmaceuticals market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Targeted Radiopharmaceuticals, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Targeted Radiopharmaceuticals market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Targeted Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Targeted Therapeutic Radiopharmaceuticals
Targeted Diagnostic Radiopharmaceuticals
Market segment by Application
Targeted Therapy
Targeted Diagnosis
Global Targeted Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Novartis
Bayer
Lantheus
Institute for Radioelements (IRE)
Radiomedix
Curium Pharma
Clarity Pharmaceuticals
ROTOP
Ratio Therapeutics
Fusion Pharmaceuticals
Perspective Therapeutics
RayzeBio
Alpha-9 Theranostics
Radiopharm Theranostics
Telix Pharmaceuticals
Ariceum Therapeutics
Aktis Oncology
Navidea Biopharmaceuticals
Nucleus RadioPharma
SmartNuclide Biopharma
TetraKit Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Targeted Radiopharmaceuticals, market overview.
Chapter 2: Global Targeted Radiopharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of Targeted Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Targeted Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Targeted Radiopharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Targeted Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Radiopharmaceuticals Overall Market Size
2.1 Global Targeted Radiopharmaceuticals Market Size: 2022 VS 2029
2.2 Global Targeted Radiopharmaceuticals Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Targeted Radiopharmaceuticals Sales: 2018-2029
3 Company Landscape
3.1 Top Targeted Radiopharmaceuticals Players in Global Market
3.2 Top Global Targeted Radiopharmaceuticals Companies Ranked by Revenue
3.3 Global Targeted Radiopharmaceuticals Revenue by Companies
3.4 Global Targeted Radiopharmaceuticals Sales by Companies
3.5 Global Targeted Radiopharmaceuticals Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Targeted Radiopharmaceuticals Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Targeted Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Targeted Radiopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 Targeted Radiopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 Targeted Radiopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Targeted Radiopharmaceuticals Market Size Markets, 2022 & 2029
4.1.2 Targeted Therapeutic Radiopharmaceuticals
4.1.3 Targeted Diagnostic Radiopharmaceuticals
4.2 By Type – Global Targeted Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type – Global Targeted Radiopharmaceuticals Revenue, 2018-2023
4.2.2 By Type – Global Targeted Radiopharmaceuticals Revenue, 2024-2029
4.2.3 By Type – Global Targeted Radiopharmaceuticals Revenue Market Share, 2018-2029
4.3 By Type – Global Targeted Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type – Global Targeted Radiopharmaceuticals Sales, 2018-2023
4.3.2 By Type – Global Targeted Radiopharmaceuticals Sales, 2024-2029
4.3.3 By Type – Global Targeted Radiopharmaceuticals Sales Market Share, 2018-2029
4.4 By Type – Global Targeted Radiopharmaceuticals Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Targeted Radiopharmaceuticals Market Size, 2022 & 2029
5.1.2 Targeted Therapy
5.1.3 Targeted Diagnosis
5.2 By Application – Global Targeted Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application – Global Targeted Radiopharmaceuticals Revenue, 2018-2023
5.2.2 By Application – Global Targeted Radiopharmaceuticals Revenue, 2024-2029
5.2.3 By Application – Global Targeted Radiopharmaceuticals Revenue Market Share, 2018-2029
5.3 By Application – Global Targeted Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application – Global Targeted Radiopharmaceuticals Sales, 2018-2023
5.3.2 By Application – Global Targeted Radiopharmaceuticals Sales, 2024-2029
5.3.3 By Application – Global Targeted Radiopharmaceuticals Sales Market Share, 2018-2029
5.4 By Application – Global Targeted Radiopharmaceuticals Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Targeted Radiopharmaceuticals Market Size, 2022 & 2029
6.2 By Region – Global Targeted Radiopharmaceuticals Revenue & Forecasts
6.2.1 By Region – Global Targeted Radiopharmaceuticals Revenue, 2018-2023
6.2.2 By Region – Global Targeted Radiopharmaceuticals Revenue, 2024-2029
6.2.3 By Region – Global Targeted Radiopharmaceuticals Revenue Market Share, 2018-2029
6.3 By Region – Global Targeted Radiopharmaceuticals Sales & Forecasts
6.3.1 By Region – Global Targeted Radiopharmaceuticals Sales, 2018-2023
6.3.2 By Region – Global Targeted Radiopharmaceuticals Sales, 2024-2029
6.3.3 By Region – Global Targeted Radiopharmaceuticals Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Targeted Radiopharmaceuticals Revenue, 2018-2029
6.4.2 By Country – North America Targeted Radiopharmaceuticals Sales, 2018-2029
6.4.3 US Targeted Radiopharmaceuticals Market Size, 2018-2029
6.4.4 Canada Targeted Radiopharmaceuticals Market Size, 2018-2029
6.4.5 Mexico Targeted Radiopharmaceuticals Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Targeted Radiopharmaceuticals Revenue, 2018-2029
6.5.2 By Country – Europe Targeted Radiopharmaceuticals Sales, 2018-2029
6.5.3 Germany Targeted Radiopharmaceuticals Market Size, 2018-2029
6.5.4 France Targeted Radiopharmaceuticals Market Size, 2018-2029
6.5.5 U.K. Targeted Radiopharmaceuticals Market Size, 2018-2029
6.5.6 Italy Targeted Radiopharmaceuticals Market Size, 2018-2029
6.5.7 Russia Targeted Radiopharmaceuticals Market Size, 2018-2029
6.5.8 Nordic Countries Targeted Radiopharmaceuticals Market Size, 2018-2029
6.5.9 Benelux Targeted Radiopharmaceuticals Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Targeted Radiopharmaceuticals Revenue, 2018-2029
6.6.2 By Region – Asia Targeted Radiopharmaceuticals Sales, 2018-2029
6.6.3 China Targeted Radiopharmaceuticals Market Size, 2018-2029
6.6.4 Japan Targeted Radiopharmaceuticals Market Size, 2018-2029
6.6.5 South Korea Targeted Radiopharmaceuticals Market Size, 2018-2029
6.6.6 Southeast Asia Targeted Radiopharmaceuticals Market Size, 2018-2029
6.6.7 India Targeted Radiopharmaceuticals Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Targeted Radiopharmaceuticals Revenue, 2018-2029
6.7.2 By Country – South America Targeted Radiopharmaceuticals Sales, 2018-2029
6.7.3 Brazil Targeted Radiopharmaceuticals Market Size, 2018-2029
6.7.4 Argentina Targeted Radiopharmaceuticals Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Targeted Radiopharmaceuticals Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Targeted Radiopharmaceuticals Sales, 2018-2029
6.8.3 Turkey Targeted Radiopharmaceuticals Market Size, 2018-2029
6.8.4 Israel Targeted Radiopharmaceuticals Market Size, 2018-2029
6.8.5 Saudi Arabia Targeted Radiopharmaceuticals Market Size, 2018-2029
6.8.6 UAE Targeted Radiopharmaceuticals Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Targeted Radiopharmaceuticals Major Product Offerings
7.1.4 Novartis Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Targeted Radiopharmaceuticals Major Product Offerings
7.2.4 Bayer Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Lantheus
7.3.1 Lantheus Company Summary
7.3.2 Lantheus Business Overview
7.3.3 Lantheus Targeted Radiopharmaceuticals Major Product Offerings
7.3.4 Lantheus Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.3.5 Lantheus Key News & Latest Developments
7.4 Institute for Radioelements (IRE)
7.4.1 Institute for Radioelements (IRE) Company Summary
7.4.2 Institute for Radioelements (IRE) Business Overview
7.4.3 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Major Product Offerings
7.4.4 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.4.5 Institute for Radioelements (IRE) Key News & Latest Developments
7.5 Radiomedix
7.5.1 Radiomedix Company Summary
7.5.2 Radiomedix Business Overview
7.5.3 Radiomedix Targeted Radiopharmaceuticals Major Product Offerings
7.5.4 Radiomedix Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.5.5 Radiomedix Key News & Latest Developments
7.6 Curium Pharma
7.6.1 Curium Pharma Company Summary
7.6.2 Curium Pharma Business Overview
7.6.3 Curium Pharma Targeted Radiopharmaceuticals Major Product Offerings
7.6.4 Curium Pharma Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.6.5 Curium Pharma Key News & Latest Developments
7.7 Clarity Pharmaceuticals
7.7.1 Clarity Pharmaceuticals Company Summary
7.7.2 Clarity Pharmaceuticals Business Overview
7.7.3 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Major Product Offerings
7.7.4 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.7.5 Clarity Pharmaceuticals Key News & Latest Developments
7.8 ROTOP
7.8.1 ROTOP Company Summary
7.8.2 ROTOP Business Overview
7.8.3 ROTOP Targeted Radiopharmaceuticals Major Product Offerings
7.8.4 ROTOP Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.8.5 ROTOP Key News & Latest Developments
7.9 Ratio Therapeutics
7.9.1 Ratio Therapeutics Company Summary
7.9.2 Ratio Therapeutics Business Overview
7.9.3 Ratio Therapeutics Targeted Radiopharmaceuticals Major Product Offerings
7.9.4 Ratio Therapeutics Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.9.5 Ratio Therapeutics Key News & Latest Developments
7.10 Fusion Pharmaceuticals
7.10.1 Fusion Pharmaceuticals Company Summary
7.10.2 Fusion Pharmaceuticals Business Overview
7.10.3 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Major Product Offerings
7.10.4 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.10.5 Fusion Pharmaceuticals Key News & Latest Developments
7.11 Perspective Therapeutics
7.11.1 Perspective Therapeutics Company Summary
7.11.2 Perspective Therapeutics Business Overview
7.11.3 Perspective Therapeutics Targeted Radiopharmaceuticals Major Product Offerings
7.11.4 Perspective Therapeutics Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.11.5 Perspective Therapeutics Key News & Latest Developments
7.12 RayzeBio
7.12.1 RayzeBio Company Summary
7.12.2 RayzeBio Business Overview
7.12.3 RayzeBio Targeted Radiopharmaceuticals Major Product Offerings
7.12.4 RayzeBio Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.12.5 RayzeBio Key News & Latest Developments
7.13 Alpha-9 Theranostics
7.13.1 Alpha-9 Theranostics Company Summary
7.13.2 Alpha-9 Theranostics Business Overview
7.13.3 Alpha-9 Theranostics Targeted Radiopharmaceuticals Major Product Offerings
7.13.4 Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.13.5 Alpha-9 Theranostics Key News & Latest Developments
7.14 Radiopharm Theranostics
7.14.1 Radiopharm Theranostics Company Summary
7.14.2 Radiopharm Theranostics Business Overview
7.14.3 Radiopharm Theranostics Targeted Radiopharmaceuticals Major Product Offerings
7.14.4 Radiopharm Theranostics Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.14.5 Radiopharm Theranostics Key News & Latest Developments
7.15 Telix Pharmaceuticals
7.15.1 Telix Pharmaceuticals Company Summary
7.15.2 Telix Pharmaceuticals Business Overview
7.15.3 Telix Pharmaceuticals Targeted Radiopharmaceuticals Major Product Offerings
7.15.4 Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.15.5 Telix Pharmaceuticals Key News & Latest Developments
7.16 Ariceum Therapeutics
7.16.1 Ariceum Therapeutics Company Summary
7.16.2 Ariceum Therapeutics Business Overview
7.16.3 Ariceum Therapeutics Targeted Radiopharmaceuticals Major Product Offerings
7.16.4 Ariceum Therapeutics Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.16.5 Ariceum Therapeutics Key News & Latest Developments
7.17 Aktis Oncology
7.17.1 Aktis Oncology Company Summary
7.17.2 Aktis Oncology Business Overview
7.17.3 Aktis Oncology Targeted Radiopharmaceuticals Major Product Offerings
7.17.4 Aktis Oncology Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.17.5 Aktis Oncology Key News & Latest Developments
7.18 Navidea Biopharmaceuticals
7.18.1 Navidea Biopharmaceuticals Company Summary
7.18.2 Navidea Biopharmaceuticals Business Overview
7.18.3 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Major Product Offerings
7.18.4 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.18.5 Navidea Biopharmaceuticals Key News & Latest Developments
7.19 Nucleus RadioPharma
7.19.1 Nucleus RadioPharma Company Summary
7.19.2 Nucleus RadioPharma Business Overview
7.19.3 Nucleus RadioPharma Targeted Radiopharmaceuticals Major Product Offerings
7.19.4 Nucleus RadioPharma Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.19.5 Nucleus RadioPharma Key News & Latest Developments
7.20 SmartNuclide Biopharma
7.20.1 SmartNuclide Biopharma Company Summary
7.20.2 SmartNuclide Biopharma Business Overview
7.20.3 SmartNuclide Biopharma Targeted Radiopharmaceuticals Major Product Offerings
7.20.4 SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.20.5 SmartNuclide Biopharma Key News & Latest Developments
7.21 TetraKit Technologies
7.21.1 TetraKit Technologies Company Summary
7.21.2 TetraKit Technologies Business Overview
7.21.3 TetraKit Technologies Targeted Radiopharmaceuticals Major Product Offerings
7.21.4 TetraKit Technologies Targeted Radiopharmaceuticals Sales and Revenue in Global (2018-2023)
7.21.5 TetraKit Technologies Key News & Latest Developments
8 Global Targeted Radiopharmaceuticals Production Capacity, Analysis
8.1 Global Targeted Radiopharmaceuticals Production Capacity, 2018-2029
8.2 Targeted Radiopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global Targeted Radiopharmaceuticals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Targeted Radiopharmaceuticals Supply Chain Analysis
10.1 Targeted Radiopharmaceuticals Industry Value Chain
10.2 Targeted Radiopharmaceuticals Upstream Market
10.3 Targeted Radiopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Targeted Radiopharmaceuticals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer